News in brief

Deerland expands branded probiotic portfolio with MuniSpore ingredient

- Last updated on GMT

© newannyart / Getty Images
© newannyart / Getty Images

Related tags: Probiotics, immune support

Georgia-based Deerland Probiotics & Enzymes has expanded its branded probiotic spore portfolio with the launch of MuniSpore positioned for immune support.

The ingredient contains Bacillus clausii​ CSI08, a soil-based microorganism, with reported benefits linked to its ability to positively influence microbial populations and its antioxidant effects on the immune system, said Deerland in a press release.

The strain’s safety and efficacy are reportedly supported by over 20 in vitro​ studies. In addition, a full genome sequencing confirmed the strain contained no plasmids, antibiotic resistant or deleterious genes, said the company.

As a spore-forming microorganism, Bacillus clausii​ protects itself from harsh conditions until entering an environment ideal for germination, such as the GI tract.  Spore-formers remains viable under a wide temperature range and do not require refrigeration, offering formulators options for a range of products, including supplements, foods and beverages. 

“The addition of MuniSpore as an option for formulation allows our customers to address the increased consumer demand for science-backed probiotic products for immune support,”  ​said Sam Michini, Deerland’s vice president of marketing and strategy.

Related news

Related products

show more

New, Novel Source of Echinacea You Can Trust

New, Novel Source of Echinacea You Can Trust

XSTO Solutions | 26-Apr-2021 | Technical / White Paper

The interest in immune support ingredients has swelled to unprecedented levels in the last year, leaving companies scrambling for consistent, clean supply...

Related suppliers

Follow us

Products

View more

Webinars